Chan Phillip P.

MedaSorb Technologies Corporation

Chief Executive Officer, Director

Avg. Two Year Performance

35% Avg. Purchase Return 16% Compound

21% Avg. Sale Return 10% Compound

Holdings: 1.16M shares

Last Three Months: 26-Aug-24 -- 25-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Medical Laboratories & Research

Health Services

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions